Nocardia keratitis after laser in situ keratomileusis: clinicopathologic correlation.

J Cataract Refract Surg

Departments of Ophthalmology, Ross Eye Institute, Buffalo, New York, USA.

Published: October 2005

AI Article Synopsis

  • A case study details a patient who developed Nocardia asteroides keratitis three weeks after undergoing LASIK in a nontraumatized eye, leading to vision loss and inflammation.
  • The initial treatment with topical antibiotics failed, necessitating a penetrating keratoplasty (PKP) surgery to address the severe infection.
  • After surgery, the patient experienced a recurrence of the infection at the graft-host interface, which was successfully treated with a combination of moxifloxacin and imipenem.

Article Abstract

A case of Nocardia asteroides keratitis occurring 3 weeks after laser in situ keratomileusis (LASIK) in a nontraumatized eye is reported. The patient presented with decreased vision, inflammation, and stromal melting of the LASIK flap, discrete infiltrates, and an anterior chamber cellular reaction. Cultures for acid-fast bacteria grew Nocardia asteroides after 5 days. Infection progressed despite treatment with topical antibiotics and eventually required penetrating keratoplasty (PKP). Postoperatively, the patient was placed on moxifloxacin, a fourth-generation flouroquinolone. The patient experienced a recurrence of Nocardia keratitis at the graft-host interface 2 months after the PKP. This eventually resolved with a combination of topical moxifloxacin and imipenem therapy.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jcrs.2005.02.049DOI Listing

Publication Analysis

Top Keywords

nocardia keratitis
8
laser situ
8
situ keratomileusis
8
nocardia asteroides
8
nocardia
4
keratitis laser
4
keratomileusis clinicopathologic
4
clinicopathologic correlation
4
correlation case
4
case nocardia
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!